CQS Cayman’s Allergan plc AGN Stock Holding History

CQS Cayman’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$13.5M	Buy	+80,000	New	+$13M	0.59%	44

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CQS Cayman's AGN Position: Q3 2019 in Review

CQS Cayman increased its Allergan plc (AGN) stake by 744% in Q3 2019, buying an estimated $9.69M and bringing the position to 67,500 shares worth $11.4M. The position accounts for 0.5% of the portfolio, ranked #48.

CQS Cayman first reported a position in AGN in Q1 2015 and has held it in 8 quarters since. The position peaked at $58.3M in Q1 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

CQS Cayman held 67,500 shares of Allergan plc worth $11.4M as of Q3 2019.
CQS Cayman bought 59,500 Allergan plc shares in Q3 2019, an estimated $9.69M.
Allergan plc made up 0.5% of CQS Cayman's portfolio in Q3 2019, its #48 holding.
CQS Cayman first reported a position in Allergan plc in Q1 2015 and has held it in 8 quarters since.
CQS Cayman's Allergan plc position peaked at $58.3M in Q1 2016.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on CQS Cayman's 13F filing for Q3 2019, filed 12 Nov 2019.